Acute Bacterial Meningitis

RESUMEN La Meningitis Bacteriana Aguda (MBA) de adquisición comunitaria es una enfermedad prevalente en todo el mundo; constituye siempre una emergencia médica y se asocia a una alta morbimortalidad. Su epidemiología es variable y los principales agentes en adultos son S .pneumoniae, N. meningitidis, H. influenzae y L. monocitogenes. En Chile existe un sistema de vigilancia recientemente implementado que permitirá un mejor diagnóstico epidemiológico. Las manifestaciones clínicas clásicas no siempre están presentes principalmente en adultos mayores. El diagnóstico requiere del estudio de líquido cefalorraquídeo, y las técnicas de biología molecular han significado un aporte relevante en los últimos años. El tratamiento antibiótico debe ser instaurado rápidamente para mejorar el pronóstico, mientras que la terapia coadyuvante con corticoides en adultos tiene sólo beneficios en etiología neumocócica. Se requieren mejores estrategias de prevención frente a una entidad que no ha cambiado su mortalidad a pesar del progreso de la medicina moderna.

• Publication year

  2020

• Venue

  Hunter's Tropical Medicine and Emerging Infectious Diseases

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/b978-0-323-55512-8.00058-2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers

  2017cited by this paper
• Impact of meningitis on intelligence and development: A systematic review and meta-analysis

  2017cited by this paper
• Goal directed therapy for suspected acute bacterial meningitis in adults and adolescents in sub-Saharan Africa

  2017cited by this paper
• Prediction of Outcome From Adult Bacterial Meningitis in a High-HIV-Seroprevalence, Resource-Poor Setting Using the Malawi Adult Meningitis Score (MAMS)

  2016cited by this paper
• An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana

  2016cited by this paper
• Safety of lumbar puncture in comatose children with clinical features of cerebral malaria

  2016cited by this paper
• Meta-analysis of studies comparing adjuvant dexamethasone to glycerol to improve clinical outcome of bacterial meningitis

  2016cited by this paper
• Ability of procalcitonin to predict bacterial meningitis in the emergency department.

  2016cited by this paper
• The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults.

  2016cited by this paper
• Corticosteroids for acute bacterial meningitis.

  2015cited by this paper
• The role of serum procalcitonin in the diagnosis of bacterial meningitis in adults: a systematic review and meta-analysis.

  2015cited by this paper
• Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.

  2015cited by this paper
• A randomized trial of protocol-based care for early septic shock.

  2014cited by this paper
• Genomic pneumococcal load and CSF cytokines are not related to outcome in Malawian adults with meningitis

  2014cited by this paper
• Bacterial meningitis in the absence of cerebrospinal fluid pleocytosis: A case report and review of the literature

  2014cited by this paper
• The effect of goal-directed therapy on mortality in patients with sepsis - earlier is better: a meta-analysis of randomized controlled trials

  2014cited by this paper
• Bacterial Meningitis in Malawian Adults, Adolescents, and Children During the Era of Antiretroviral Scale-up and Haemophilus influenzae Type b Vaccination, 2000–2012

  2014cited by this paper
• Added value of PCR-testing for confirmation of invasive meningococcal disease in England.

  2013cited by this paper
• The changing pattern of bacterial meningitis in adult patients at a large tertiary university hospital in Barcelona, Spain (1982-2010).

  2013cited by this paper
• The Austrian syndrome: a case report and review of the literature

  2013cited by this paper
• The pneumococcus: epidemiology, microbiology, and pathogenesis.

  2013cited by this paper
• Bacterial Meningitis in the United States, 1998–2007

  2013cited by this paper
• Corticosteroids for acute bacterial meningitis (Review)

  2013cited by this paper
• Risk Factors for Death and Severe Sequelae in Malawian Children With Bacterial Meningitis, 1997–2010

  2013cited by this paper
• Clinical review: Goal-directed therapy-what is the evidence in surgical patients? The effect on different risk groups

  2013cited by this paper
• Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals

  2012cited by this paper
• Meningococcal disease: changes in epidemiology and prevention

  2012cited by this paper
• Bacterial meningitis among children under the age of 2 years in a high human immunodeficiency virus prevalence area after Haemophilus influenzae type b vaccine introduction

  2012cited by this paper
• Dilemmas in the diagnosis of acute community-acquired bacterial meningitis.

  2012cited by this paper
• Factors associated with the occurrence of hearing loss after pneumococcal meningitis.

  2011cited by this paper
• Increased Risk of Death in Human Immunodeficiency Virus-infected Children With Pneumococcal Meningitis in South Africa, 2003–2005

  2011cited by this paper
• Incorporation of Real-Time PCR into Routine Public Health Surveillance of Culture Negative Bacterial Meningitis in São Paulo, Brazil

  2011cited by this paper
• Mortality after fluid bolus in African children with severe infection.

  2011cited by this paper
• 5 versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study.

  2011cited by this paper
• The implications of vaccines for prevention of bacterial meningitis

  2010cited by this paper
• Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases

  2010cited by this paper
• A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene.

  2010cited by this paper
• Diagnosis of cryptococcal and tuberculous meningitis in a resource‐limited African setting

  2010cited by this paper
• The Evaluation and Management of Bacterial Meningitis: Current Practice and Emerging Developments

  2010cited by this paper
• Acute bacterial meningitis in infants and children.

  2010cited by this paper
• Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data

  2010cited by this paper
• Global epidemiology of meningococcal disease.

  2009cited by this paper
• Emerging drugs for acute bacterial meningitis

  2009cited by this paper
• Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models.

  2009cited by this paper
• Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance.

  2009cited by this paper
• British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children.

  2009cited by this paper
• Risk factors for death and severe neurological sequelae in childhood bacterial meningitis in sub-Saharan Africa.

  2009cited by this paper
• Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: Expansion of ST217 hypervirulent clonal complex in West Africa

  2008cited by this paper
• Fluid therapy for acute bacterial meningitis.

  2008cited by this paper
• The diagnosis and management of acute bacterial meningitis in resource-poor settings.

  2008cited by this paper
• High Pneumococcal DNA Loads Are Associated With Mortality in Malawian Children With Invasive Pneumococcal Disease

  2007cited by this paper
• Corticosteroids for acute bacterial meningitis.

  2007cited by this paper
• Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis.

  2007cited by this paper
• New Rapid Diagnostic Tests for Neisseria meningitidis Serogroups A, W135, C, and Y

  2006cited by this paper
• Prospects for Vaccine Prevention of Meningococcal Infection

  2006influential reference
• Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso.

  2006cited by this paper
• Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis.

  2005cited by this paper
• Indicators of Acute Bacterial Meningitis in Children at a Rural Kenyan District Hospital

  2004cited by this paper
• Practice guidelines for the management of bacterial meningitis.

  2004influential reference
• Bacterial meningitis--a view of the past 90 years.

  2004cited by this paper
• Clinical features and prognostic factors in adults with bacterial meningitis.

  2004cited by this paper
• Dexamethasone in adults with bacterial meningitis.

  2003cited by this paper
• A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.

  2003cited by this paper
• Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases.

  2003cited by this paper
• The effect of HIV infection on paediatric bacterial meningitis in Blantyre, Malawi

  2003cited by this paper
• Neurological diseases: Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury

  2003cited by this paper
• Pathogenesis and pathophysiology of pneumococcal meningitis.

  2002cited by this paper
• Management of meningitis in children with oral fluid restriction or intravenous fluid at maintenance volumes: a randomised trial

  2002cited by this paper
• Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features.

  2002cited by this paper
• Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock

  2001cited by this paper
• Changing epidemiology of bacterial meningitis in the United States

  2000cited by this paper
• Randomized trial of four vs. seven days of ceftriaxone treatment for bacterial meningitis in children with rapid initial recovery

  2000cited by this paper
• Community-Acquired Bacterial Meningitis: Risk Stratification for Adverse Clinical Outcome and Effect of Antibiotic Timing

  1998cited by this paper
• PCR of peripheral blood for diagnosis of meningococcal disease

  1996cited by this paper
• Bacterial Meningitis in Children

  1992cited by this paper
• Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations.

  1989cited by this paper
• Acute bacterial meningitis.

  1956cited by this paper
• Research Article ( New England Journal of Medicine) A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults

  year unknowncited by this paper

• No citing papers are available for this paper.